Fact CheckerSign in

NCT05722847Completed

Risk Stratification for Patients With Hospital-diagnosed Advanced Lung Cancer

Development of an Enhanced Risk Stratification System for Patients With Hospital-diagnosed Advanced Lung Cancer

Source: ClinicalTrials.gov · Last updated 25 May 2025

Brief summary (registry, in English)

This study explores whether supportive care interventions that might reduce rehospitalization could be implemented and feasible, in subjects within a high-risk group of subjects with newly diagnosed hospitalized advanced lung cancer (ALC). This study screened 50 subjects from health records and consented to 15 of these screened subjects. These 15 subjects responded to PRO questionnaires.

Status (registry)
Completed
Study type
Observational
Enrollment
18 (actual)
First submitted
26 Jan 2023
Start date
14 Mar 2023
Primary completion date
5 Jan 2025
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Diseases
Lung cancer
NCT number
NCT05722847

What you commit to

  • Study type: Observational
  • Participants enrolled: 18
  • From 14 Mar 2023 to the primary completion date, 5 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Dementia, altered mental status, or any psychiatric condition as determined by the clinical or study team that would prohibit the understanding or rendering of informed consent.
  • Any condition that would prohibit the patient from completing PROs

Other

  • 1\. Enrollment in hospice upon discharge from the index hospitalization For PROs only
  • Inability to read or speak English.
  • Current incarceration.

Who the study is looking for

  • Age ≥ 18 years at the time of screening.
  • Hospital-diagnosed Advanced lung cancer with histological confirmation of disease or suspected lung cancer in the opinion of the treating oncologist.
    • For PROs only
    • 1\. Able to complete a web-based or telephonic symptom survey.
  • 1\. Thoracic medical oncology physicians, advance practice providers, and nurse navigators work in the study site and respond to the survey that assesses acceptability.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UNC Lineberger
Coordinator of this site? Confirm its status
Chapel HillUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.